Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | OCGN |
---|---|---|
09:32 ET | 38181 | 0.975 |
09:34 ET | 41058 | 0.9614 |
09:36 ET | 15149 | 0.9588 |
09:38 ET | 8617 | 0.9668 |
09:39 ET | 9691 | 0.9668 |
09:41 ET | 1662 | 0.958499 |
09:43 ET | 4955 | 0.9602 |
09:45 ET | 19498 | 0.9551 |
09:48 ET | 60371 | 0.955 |
09:50 ET | 10112 | 0.955 |
09:52 ET | 13050 | 0.955 |
09:54 ET | 15078 | 0.955 |
09:56 ET | 10342 | 0.955 |
09:57 ET | 9362 | 0.9591 |
09:59 ET | 12100 | 0.955 |
10:01 ET | 7637 | 0.955 |
10:03 ET | 15626 | 0.955028 |
10:06 ET | 130080 | 0.9449 |
10:08 ET | 5400 | 0.9416 |
10:10 ET | 13101 | 0.9427 |
10:12 ET | 3116 | 0.9432 |
10:14 ET | 39249 | 0.9425 |
10:15 ET | 2150 | 0.9415 |
10:17 ET | 5551 | 0.9431 |
10:19 ET | 35605 | 0.943 |
10:21 ET | 6215 | 0.9465 |
10:24 ET | 11438 | 0.9484 |
10:26 ET | 2711 | 0.9448 |
10:28 ET | 4965 | 0.947599 |
10:30 ET | 1499 | 0.9459 |
10:32 ET | 15894 | 0.94565 |
10:33 ET | 15550 | 0.9462 |
10:35 ET | 38652 | 0.942 |
10:37 ET | 7827 | 0.942099 |
10:39 ET | 4209 | 0.9421 |
10:42 ET | 22706 | 0.9425 |
10:44 ET | 13133 | 0.94 |
10:46 ET | 3470 | 0.94 |
10:48 ET | 114899 | 0.9362 |
10:50 ET | 124177 | 0.9351 |
10:51 ET | 21210 | 0.94279 |
10:53 ET | 8776 | 0.9427 |
10:55 ET | 1500 | 0.9428 |
10:57 ET | 8171 | 0.942 |
11:00 ET | 6333 | 0.9419 |
11:02 ET | 128574 | 0.94 |
11:04 ET | 2284 | 0.9434 |
11:06 ET | 6115 | 0.9414 |
11:08 ET | 4779 | 0.93835 |
11:09 ET | 10220 | 0.9409 |
11:11 ET | 4201 | 0.938375 |
11:13 ET | 6441 | 0.9367 |
11:15 ET | 100 | 0.935 |
11:18 ET | 9466 | 0.9385 |
11:20 ET | 44092 | 0.9374 |
11:22 ET | 14724 | 0.9374 |
11:24 ET | 1644 | 0.9411 |
11:26 ET | 1644 | 0.9452 |
11:27 ET | 1870 | 0.9433 |
11:29 ET | 12485 | 0.9457 |
11:31 ET | 736 | 0.947 |
11:33 ET | 1000 | 0.9469 |
11:36 ET | 4900 | 0.9441 |
11:38 ET | 300 | 0.94 |
11:42 ET | 3101 | 0.9439 |
11:44 ET | 100 | 0.942 |
11:45 ET | 7640 | 0.9439 |
11:47 ET | 16358 | 0.9421 |
11:49 ET | 680 | 0.9431 |
11:54 ET | 4663 | 0.943 |
11:56 ET | 2415 | 0.9421 |
11:58 ET | 11442 | 0.9421 |
12:00 ET | 6645 | 0.9438 |
12:02 ET | 3600 | 0.9423 |
12:03 ET | 2582 | 0.9404 |
12:05 ET | 200 | 0.9416 |
12:07 ET | 1094 | 0.9404 |
12:09 ET | 1299 | 0.942 |
12:12 ET | 959 | 0.9403 |
12:14 ET | 2060 | 0.9401 |
12:16 ET | 8232 | 0.9401 |
12:18 ET | 1149 | 0.9413 |
12:20 ET | 5520 | 0.9413 |
12:21 ET | 6122 | 0.9412 |
12:23 ET | 35714 | 0.9495 |
12:27 ET | 1252 | 0.946649 |
12:30 ET | 200 | 0.9483 |
12:32 ET | 10739 | 0.9483 |
12:34 ET | 6404 | 0.947 |
12:36 ET | 1580 | 0.94695 |
12:38 ET | 8900 | 0.9467 |
12:41 ET | 700 | 0.9454 |
12:43 ET | 11422 | 0.94 |
12:45 ET | 5291 | 0.940341 |
12:48 ET | 12892 | 0.9429 |
12:50 ET | 3591 | 0.943 |
12:52 ET | 500 | 0.943 |
12:54 ET | 2857 | 0.9423 |
12:56 ET | 4241 | 0.9423 |
12:57 ET | 10879 | 0.941 |
12:59 ET | 6518 | 0.9409 |
01:01 ET | 5084 | 0.937 |
01:03 ET | 10337 | 0.9396 |
01:06 ET | 818 | 0.94 |
01:08 ET | 406 | 0.9395 |
01:10 ET | 8606 | 0.93895 |
01:12 ET | 3392 | 0.938 |
01:14 ET | 15790 | 0.9409 |
01:15 ET | 4441 | 0.9404 |
01:17 ET | 3367 | 0.94 |
01:19 ET | 200 | 0.941 |
01:21 ET | 1599 | 0.9399 |
01:24 ET | 4891 | 0.937 |
01:26 ET | 2435 | 0.9351 |
01:28 ET | 18066 | 0.934 |
01:30 ET | 3300 | 0.9337 |
01:32 ET | 6393 | 0.9341 |
01:33 ET | 1222 | 0.93365 |
01:35 ET | 8218 | 0.933575 |
01:37 ET | 5418 | 0.9329 |
01:39 ET | 186463 | 0.930501 |
01:42 ET | 139058 | 0.9284 |
01:44 ET | 16254 | 0.9255 |
01:46 ET | 9332 | 0.9254 |
01:48 ET | 7234 | 0.9228 |
01:50 ET | 2323 | 0.9244 |
01:51 ET | 7457 | 0.92415 |
01:53 ET | 20441 | 0.9239 |
01:55 ET | 6685 | 0.93 |
01:57 ET | 4756 | 0.926599 |
02:00 ET | 3957 | 0.9268 |
02:02 ET | 2216 | 0.92455 |
02:04 ET | 19419 | 0.9247 |
02:06 ET | 10627 | 0.9291 |
02:08 ET | 5768 | 0.923 |
02:09 ET | 6600 | 0.9248 |
02:11 ET | 1780 | 0.9251 |
02:13 ET | 6778 | 0.92355 |
02:15 ET | 17459 | 0.9253 |
02:18 ET | 4920 | 0.9229 |
02:20 ET | 19351 | 0.9225 |
02:22 ET | 593 | 0.9243 |
02:24 ET | 14289 | 0.92 |
02:26 ET | 3210 | 0.92 |
02:27 ET | 11314 | 0.9207 |
02:29 ET | 19779 | 0.92 |
02:31 ET | 29346 | 0.9205 |
02:33 ET | 14852 | 0.9209 |
02:36 ET | 24486 | 0.9198 |
02:38 ET | 28090 | 0.915 |
02:40 ET | 44213 | 0.9163 |
02:42 ET | 7664 | 0.9177 |
02:44 ET | 24696 | 0.9177 |
02:45 ET | 7663 | 0.919399 |
02:47 ET | 5737 | 0.91725 |
02:49 ET | 16608 | 0.9176 |
02:51 ET | 3884 | 0.9162 |
02:54 ET | 6100 | 0.918299 |
02:56 ET | 13700 | 0.91715 |
02:58 ET | 24201 | 0.9202 |
03:00 ET | 6451 | 0.9238 |
03:02 ET | 2857 | 0.9183 |
03:03 ET | 300 | 0.9183 |
03:05 ET | 45426 | 0.9191 |
03:07 ET | 6984 | 0.9237 |
03:09 ET | 1200 | 0.92185 |
03:12 ET | 3685 | 0.9201 |
03:14 ET | 2800 | 0.921 |
03:16 ET | 7367 | 0.9201 |
03:18 ET | 3983 | 0.9201 |
03:20 ET | 17514 | 0.921 |
03:21 ET | 3000 | 0.921 |
03:23 ET | 11921 | 0.9203 |
03:25 ET | 61566 | 0.9201 |
03:27 ET | 4882 | 0.92 |
03:30 ET | 7455 | 0.9183 |
03:32 ET | 7130 | 0.9161 |
03:34 ET | 30248 | 0.911 |
03:36 ET | 83982 | 0.9087 |
03:38 ET | 14744 | 0.9115 |
03:39 ET | 16290 | 0.9197 |
03:41 ET | 16312 | 0.914 |
03:43 ET | 11953 | 0.9101 |
03:45 ET | 10741 | 0.913 |
03:48 ET | 98953 | 0.91405 |
03:50 ET | 4789 | 0.913 |
03:52 ET | 88433 | 0.9267 |
03:54 ET | 15299 | 0.9155 |
03:56 ET | 51754 | 0.9143 |
03:57 ET | 28023 | 0.9218 |
03:59 ET | 331539 | 0.911 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ocugen Inc | 280.4M | -5.1x | --- |
Abeona Therapeutics Inc | 275.5M | -3.0x | --- |
Molecular Partners AG | 253.6M | -2.7x | --- |
Atea Pharmaceuticals Inc | 276.9M | -1.5x | --- |
Inozyme Pharma Inc | 284.8M | -2.9x | --- |
Lexeo Therapeutics Inc | 273.6M | -2.8x | --- |
Ocugen, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines that improve health for patients across the globe. Its technology pipeline includes modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases. The Company is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal disease (IRDs), including retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Stargardt disease and multifactorial diseases such as dry age-related macular degeneration (dAMD) and geographic atrophy (GA). It is developing an inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $280.4M |
---|---|
Revenue (TTM) | $8.2M |
Shares Outstanding | 287.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.75 |
EPS | $-0.18 |
Book Value | $0.16 |
P/E Ratio | -5.1x |
Price/Sales (TTM) | 34.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -631.33% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.